Citation: Hl. White et al., UTILIZATION OF TRANSLUMINAL EXTRACTION ATHERECTOMY IN THE TREATMENT OF SAPHENOUS-VEIN GRAFT DISEASE - 2 CASE-REPORTS, International journal of cardiology, 66(1), 1998, pp. 11-15
Citation: M. Harfenist et al., SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE (MAO) - 5 - 1-SUBSTITUTED PHENOXATHIIN INHIBITORS CONTAINING NO NITROGEN THAT INHIBIT MAO-A BY BINDING IT TO A HYDROPHOBIC SITE, Journal of medicinal chemistry, 41(12), 1998, pp. 2118-2125
Citation: Rn. White et al., NATURALLY-OCCURRING XANTHINE UROLITHIASIS IN A DOMESTIC SHORTHAIR CAT, Journal of Small Animal Practice, 38(7), 1997, pp. 299-301
Authors:
HARFENIST M
JOSEPH DM
SPENCE SC
MCGEE DPC
REEVES MD
WHITE HL
Citation: M. Harfenist et al., SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE .4. SAR OF TRICYCLIC N-METHYLCARBOXAMIDES AND CONGENERS BINDING AT THE TRICYCLICS HYDROPHILIC BINDING-SITE, Journal of medicinal chemistry, 40(16), 1997, pp. 2466-2473
Authors:
HARFENIST M
HEUSER DJ
JOYNER CT
BATCHELOR JF
WHITE HL
Citation: M. Harfenist et al., SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE .3. STRUCTURE-ACTIVITY RELATIONSHIP OF TRICYCLICS BEARING IMIDAZOLINE, OXADIAZOLE, OR TETRAZOLE GROUPS, Journal of medicinal chemistry, 39(9), 1996, pp. 1857-1863
Citation: Hl. White, NAVAL ELECTRICAL-POWER IN COMMERCIAL USE (REPRINTED FROM THE JOURNAL OF THE AMERICAN SOCIETY OF NAVAL ENGINEERS, VOLUME 43, NO 2, MAY 1930), Naval engineers journal, 107(1), 1995, pp. 109-113
Citation: M. Harfenist et al., SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE .2. ARYLAMIDE SAR, Journal of medicinal chemistry, 37(13), 1994, pp. 2085-2089
Authors:
WATERHOUSE RN
SILCOCK DJ
WHITE HL
BUHARIWALLA HK
GLOVER LA
Citation: Rn. Waterhouse et al., THE CLONING AND CHARACTERIZATION OF PHAGE PROMOTERS, DIRECTING HIGH EXPRESSION OF LUCIFERASE IN PSEUDOMONAS-SYRINGAE PV PHASEOLICOLA, ALLOWING SINGLE-CELL AND MICROCOLONY DETECTION, Molecular ecology, 2(5), 1993, pp. 285-294
Citation: Hl. White et Ja. Ascher, PRECLINICAL AND EARLY CLINICAL-STUDIES WITH BW-1370U87, A REVERSIBLE COMPETITIVE MONOAMINE OXIDASE-A INHIBITOR, Clinical neuropharmacology, 16, 1993, pp. 190000025-190000033
Authors:
HEDEEN KM
WHITE HL
COOPER BR
CONNER GW
NORTON RM
Citation: Km. Hedeen et al., EFFECT OF A NOVEL MONOAMINE OXIDASE-A INHIBITOR, BW 1370U87, ON URINARY 3-METHOXY-4-HYDROXYPHENYLGLYCOL IN NORMAL VOLUNTEERS, Drug development research, 30(1), 1993, pp. 24-29
Authors:
COOPER BR
WHITE HL
BEEK O
NORTON RM
RIGDON GC
HOWARD JL
KRAEMER GW
FERRIS RM
Citation: Br. Cooper et al., OVERVIEW OF THE CNS PHARMACOLOGY OF BW-1370U87 - A CHEMICALLY NOVEL, REVERSIBLE, SELECTIVE MAO-A INHIBITOR WITH POTENTIAL TO BE A NEW ANTIDEPRESSANT DRUG, Drug development research, 25(3), 1992, pp. 181-190
Authors:
JONESHUMBLE SA
NORTON RM
WHITE HL
COOPER BR
Citation: Sa. Joneshumble et al., BW-1370U87, A NEW MONOAMINE OXIDASE-A INHIBITOR - EFFECTS ON BIOGENIC-AMINE NEUROTRANSMITTER AND METABOLITE LEVELS IN RAT-BRAIN, Drug development research, 25(3), 1992, pp. 201-207
Citation: Rm. Norton et al., METABOLISM OF BW-1370U87 BY CRUDE LIVER HOMOGENATES FROM SEVERAL SPECIES - AN INVITRO METHOD FOR PRELIMINARY INVESTIGATION OF SPECIES-DIFFERENCES IN METABOLISM, Drug development research, 25(3), 1992, pp. 229-234